2025年，中国资本市场"零容忍"监管态势持续升级，针对一批连续多年、系统性财务造假的上市公司， 中国证监会等监管部门严厉打击、严肃惩处，形成应退尽退、及时出清的常态化退市格局。据记者统 计，今年以来，已有12家上市公司触及重大违法强制退市情形，相继终止上市或进入退市程序，部分公 司触发重大违法强制退市后，股价一路下跌最终以面值退市等交易类强制退市情形率先退出市场。此 外，还有40余家上市公司因财务造假、信息披露违规等事项，在收到证监会《行政处罚事先告知书》 后，被实施其他风险警示（ST）。（上海证券报） ...

Core Viewpoint - Jiangsu Wuzhong, once a prominent player in the education apparel sector, is facing delisting after being mismanaged and financially manipulated by its major shareholders, leading to significant losses for its investors [2][16]. Company History and Performance - Jiangsu Wuzhong was established as a state-owned enterprise focused on textile and later diversified into real estate and chemical industries, but faced challenges in each sector, ultimately leading to its decline [2][8]. - The company transitioned to a medical aesthetics focus under the control of the Qian siblings, who acquired a 17.01% stake in 2018 for 707 million yuan [6][10]. Financial Manipulation and Fraud - The previous major shareholders engaged in tax fraud through a related export company, which led to significant financial gains at the expense of the company [9][10]. - Under the Qian siblings' management, the company allegedly inflated revenues by 1.7 billion yuan and profits by 76 million yuan over four years through fictitious trading activities [10][11]. - By 2024, the company had occupied 17 billion yuan of its net assets, indicating severe financial distress and misappropriation of funds [12]. Regulatory Actions and Consequences - Jiangsu Wuzhong faced a 10 million yuan fine from regulators, while the Qian siblings were fined a total of 12 million yuan, with one sibling receiving a 10-year market ban [16]. - The company is now subject to potential criminal liability and shareholder lawsuits due to its fraudulent activities and subsequent financial collapse [16].

Core Viewpoint - The report highlights the increasing number of securities-related disputes in Beijing, emphasizing the prevalence of securities fraud cases and the expanding range of liable parties involved in these disputes [1][2][3][5]. Group 1: Case Statistics - From March 2021 to August 2025, the Beijing Financial Court accepted a total of 10,942 securities commercial cases, with a significant portion being securities fraud liability disputes [2][3]. - The total amount involved in securities dispute cases reached 45.928 billion yuan, with an average litigation amount of approximately 4.1974 million yuan per case [2][7]. - The number of securities fraud liability disputes accounted for 99.8% of all fraud-related cases, indicating a dominant trend in the types of disputes being filed [4]. Group 2: Types of Disputes - The report categorizes securities fraud liability disputes into four main types: false statements, insider trading, market manipulation, and fraud against clients, with false statements being the most common [4]. - The majority of cases involve false statements related to financial misrepresentation, misleading statements, and failure to disclose critical information [4]. Group 3: Involved Parties - A total of 45 intermediary institutions have been sued, including 11 securities companies, 19 accounting firms, 6 law firms, 5 asset appraisal agencies, and 4 credit rating agencies [5][6]. - The report notes that investors are increasingly suing not only the issuers but also their controlling shareholders, actual controllers, and senior executives, reflecting a trend towards broader accountability [5][6]. Group 4: Emerging Issues - The report identifies new challenges arising from the complexity of financial products and trading models, including potential lawsuits related to companies facing delisting due to fraud [8]. - There is a growing concern regarding large shareholders' illegal share reductions, which may lead to securities fraud claims, especially in light of new regulations governing share reductions [8][9]. - The report anticipates an increase in civil claims related to insider trading and market manipulation as investor awareness and legal frameworks evolve [9].

Core Viewpoint - The company *ST Tianmao has received a decision from the Shenzhen Stock Exchange to terminate its stock listing due to continuous financial losses and failure to meet reporting obligations [1][5]. Group 1: Company Overview - *ST Tianmao was established in November 1993 and listed on the Shenzhen Stock Exchange in November 1996, primarily engaged in various personal insurance businesses including life, health, and accident insurance [4]. Group 2: Delisting Process - The company announced its intention to voluntarily delist on August 8, 2023, submitted the delisting application on September 4, and the Shenzhen Stock Exchange accepted the application on September 10, with the final decision made on September 25, 2023, completing the delisting process in approximately two months [3][5]. Group 3: Financial Performance - The company's net profit attributable to shareholders has declined for four consecutive years, with significant losses in the last two years. The net profit figures from 2020 to 2023 show a decline of 67.32%, 18.88%, 41.78%, and 337.82%, respectively. In 2023, the company reported a net loss of 650 million yuan, and for the first three quarters of 2024, the loss was 333 million yuan [5]. - The company projected a net loss of 500 million to 750 million yuan for 2024, with a non-recurring net profit loss forecasted between 503 million and 753 million yuan [5]. Group 4: Regulatory Compliance and Risks - Prior to the voluntary delisting, the company had issued multiple risk warning announcements regarding the potential for termination of its listing due to its inability to disclose the 2024 annual report and the 2025 Q1 report within the statutory timeframe [6]. - Since 2025, a total of 25 listed companies, including B-share companies, have completed the delisting process, with nine companies facing financial delisting, indicating a broader trend in the market [6].

Core Viewpoint - The company *ST Tianmao has been delisted from the Shenzhen Stock Exchange due to continuous financial losses and has initiated a voluntary delisting process, which took approximately two months to complete [1][2][4]. Summary by Sections Delisting Announcement - On September 25, *ST Tianmao received a decision from the Shenzhen Stock Exchange to terminate its stock listing, effective within five trading days [1][2]. - The company will not enter a delisting transition period as it voluntarily chose to delist [2]. Company Background - *ST Tianmao was established in November 1993 and listed on the Shenzhen Stock Exchange in November 1996, primarily engaging in various life and health insurance businesses [4]. Financial Performance - The company's financial performance has deteriorated for four consecutive years, with significant losses in the last two years [5]. - From 2020 to 2023, the net profit attributable to shareholders decreased by 67.32%, 18.88%, 41.78%, and 337.82%, respectively [5]. - In 2023, the company reported a net loss of 650 million yuan, and for the first three quarters of 2024, the loss was 333 million yuan [5]. - A forecast for 2024 indicated expected losses between 500 million to 750 million yuan [5]. Delisting Process - The entire delisting process took about two months, starting from the initial announcement of voluntary delisting on August 8 [2][4]. - Prior to the delisting, the company had issued multiple risk warnings regarding the potential for termination of its listing [6]. Industry Context - Since 2025, a total of 25 companies, including B-share companies, have completed the delisting process, with various reasons including financial issues and voluntary delisting [6].

Core Viewpoint - The article discusses the circumstances under which a listed company may be delisted, emphasizing the importance of protecting investors' rights in cases of financial fraud and other violations [1][2]. Group 1: Types of Delisting - Delisting can occur in two main forms: voluntary delisting, where a company chooses to withdraw from the stock exchange, and involuntary delisting, which is enforced by the exchange due to non-compliance with listing requirements [1]. - Involuntary delisting is categorized into four types: trading-related, financial-related, compliance-related, and major violation delisting, with financial fraud falling under the major violation category [1][2]. Group 2: Impact of Financial Fraud - Financial fraud involves companies artificially inflating revenues or profits to mislead investors, as exemplified by Beijing Orient Technology Co., which was reported for falsifying financial data over four consecutive years [2]. - While delisting may disappoint investors, it serves to protect their interests by removing companies that distort market pricing mechanisms and fail to provide accurate financial information [2]. Group 3: Investor Rights and Compensation - Delisting does not automatically entitle investors to compensation; only in cases of financial fraud or other illegal activities leading to delisting can investors seek damages [3]. - Investors have various legal avenues to assert their rights, including administrative buybacks, advance compensation, and litigation, particularly in cases of false statements or disclosures [3][4]. Group 4: Importance of Evidence and Timeliness - Investors are advised to retain evidence such as transaction records and to stay informed about regulatory actions, as these are crucial for any potential claims [4]. - The success of obtaining compensation post-litigation depends on the company's ability to pay and the court's enforcement capabilities [4]. Group 5: Conclusion - Understanding the complexities of delisting and investor rights is essential for investors to protect their legal interests and make informed investment decisions [5].

Core Points - Two companies in the Shenzhen Stock Exchange, *ST Zitian and *ST Tianmao, are facing delisting, with *ST Zitian being forced to delist due to regulatory violations and *ST Tianmao voluntarily applying for delisting [2][5] - A total of 24 companies have been delisted from the A-share market this year, with over 80% of these companies delisted due to severe violations related to financial, regulatory, and trading rules [2][5] - Delisting does not exempt companies from legal responsibilities, as they may still face administrative, criminal, and civil liabilities post-delisting [2][5] Summary of *ST Zitian - *ST Zitian's stock will be suspended from trading on September 15 and will enter a delisting preparation period lasting 15 trading days, with the last trading day expected to be October 13 [3] - The company was found to have falsified financial reports, inflating revenue by 2.499 billion yuan and profits by over 100 million yuan through fraudulent activities [3][4] - The company and its management faced fines totaling 38.4 million yuan, with key executives banned from the securities market for life due to continuous financial fraud and obstruction of regulatory inspections [4] Summary of *ST Tianmao - *ST Tianmao has submitted a voluntary delisting application after failing to disclose its 2024 annual report and 2025 Q1 report within the legal timeframe [5] - The company offered a cash option to dissenting shareholders at a price of 1.60 yuan per share as part of its delisting plan [5] - The trend of regular delistings has accelerated, with a significant number of companies facing strict enforcement of delisting regulations [5] Post-Delisting Accountability - Companies that have been delisted, such as Longyu, continue to face penalties for past violations, with fines imposed for financial misconduct and market bans for key individuals [6] - Regulatory bodies are emphasizing the importance of accountability for delisted companies to prevent evasion of responsibilities [5][6]

Core Viewpoint - The article discusses the recent trend of delistings in the A-share market, highlighting that companies are facing stricter regulations and potential legal consequences even after delisting due to financial misconduct and other violations [3][10]. Group 1: Recent Delistings - Two companies, *ST Zitian and *ST Tianmao, have recently been involved in delisting activities, with *ST Zitian facing a forced delisting due to regulatory violations [3][11]. - As of September 7, 2023, a total of 24 companies have been delisted this year, with over 80% of these cases attributed to severe legal, financial, and regulatory breaches [3][11]. Group 2: Regulatory Actions and Consequences - *ST Zitian was found to have inflated its revenue by CNY 2.499 billion and profits by over CNY 100 million through fraudulent accounting practices, leading to administrative penalties and potential criminal charges [7][9]. - The company has been penalized a total of CNY 38.4 million, and its former chairman and CFO have been banned from the securities market for life due to their involvement in the misconduct [9]. - Following its delisting, *ST Longyu also faced significant penalties for similar financial misreporting, indicating a trend of continued regulatory scrutiny post-delistings [12]. Group 3: Market Trends and Future Implications - The article notes an acceleration in the pace of delistings, with a clear emphasis from regulators on enforcing strict delisting rules and holding companies accountable for their actions [11][12]. - The proactive delisting by *ST Tianmao, which offered cash options to dissenting shareholders, reflects a growing trend among companies to manage their exit from the market strategically [11].

Core Viewpoint - *ST Tianmao has announced its decision to voluntarily delist from the Shenzhen Stock Exchange due to significant uncertainties in its business structure, aiming to protect the interests of minority shareholders [1][3]. Company Overview - *ST Tianmao, established in November 1993 and listed in November 1996, primarily engages in various life insurance businesses [5]. - The company was previously known as Baike Pharmaceutical and underwent a significant ownership change in December 2002 when New Liyi Group acquired a controlling stake [5][6]. Financial Performance - The company experienced a dramatic increase in revenue after acquiring a 43.86% stake in Guohua Life Insurance in 2016, leading to revenues soaring from several hundred million to over 500 billion in 2019 [6]. - However, 2020 marked a turning point, with Guohua Life's net profit dropping to 1.11 billion, followed by continuous declines, resulting in a net loss of 1.155 billion in 2023, a year-on-year decrease of 338.6% [7]. - The company's net profit has declined for four consecutive years, with figures showing a drop of 67.32%, 18.88%, 41.78%, and 337.82% from 2020 to 2023 [7]. Delisting Process - The company has set up mechanisms to protect dissenting shareholders, offering a cash option at a price of 1.60 CNY per share, which is approximately 10.34% above the suspension price of 1.45 CNY [3]. - If the shareholders do not approve the delisting resolution, they will not be eligible for the cash option and cannot claim any compensation [3]. - The stock has been suspended since May 6, 2025, due to the company's failure to disclose its annual report and quarterly report within the legal timeframe [4]. Industry Context - As of 2025, a total of 24 companies have completed the delisting process, with various reasons including financial issues and voluntary applications [8][10]. - The primary reasons for delisting include financial performance failures and significant legal violations, indicating a challenging environment for companies in the market [10].

Core Viewpoint - *ST Tianmao has applied for voluntary delisting from the Shenzhen Stock Exchange due to significant uncertainties arising from business restructuring, aiming to protect the interests of minority shareholders [2][5][7]. Group 1: Delisting Announcement - *ST Tianmao's board has approved a resolution to withdraw its A-share listing and will apply to transfer to the National Equities Exchange and Quotations for management in the delisting section [1]. - The company will provide cash options to shareholders, with an exercise price of 1.60 CNY per share, representing a premium of approximately 10.34% over the suspension price of 1.45 CNY [6]. Group 2: Financial Performance - The company has faced continuous declines in performance, with net profits dropping for four consecutive years, including a significant loss of 11.55 billion CNY in 2023, a year-on-year decline of 338.6% [13][14]. - From 2020 to 2023, the company's net profit attributable to shareholders decreased by 67.32%, 18.88%, 41.78%, and 337.82%, respectively [14]. Group 3: Historical Context - Established in November 1993 and listed in November 1996, *ST Tianmao primarily engages in various life insurance businesses [10]. - The company underwent significant changes in ownership and control, with New Liyi Group becoming the major shareholder in 2002 [10][11]. - The acquisition of a 43.86% stake in Guohua Life Insurance in 2016 marked a turning point, leading to substantial revenue growth, peaking at over 500 billion CNY in 2019 [12]. Group 4: Industry Context - As of 2025, a total of 24 companies have completed delisting, with various reasons including financial issues and voluntary applications [17][20]. - The primary reasons for delisting include financial performance issues and violations of regulations, indicating a challenging environment for companies in the market [20].